ACT OXALIPLATIN Solution

Country: Կանադա

language: ֆրանսերեն

source: Health Canada

active_ingredient:

Oxaliplatine

MAH:

ACTAVIS PHARMA COMPANY

ATC_code:

L01XA03

INN:

OXALIPLATIN

dosage:

5MG

pharmaceutical_form:

Solution

composition:

Oxaliplatine 5MG

administration_route:

Intraveineuse

units_in_package:

10/20/40ML

prescription_type:

Prescription

therapeutic_area:

ANTINEOPLASTIC AGENTS

leaflet_short:

Numéro de groupe d'ingrédients actifs (GIA) :0152220003; AHFS:

authorization_status:

ANNULÉ APRÈS COMMERCIALISATION

authorization_date:

2018-07-09